(Q54077957)

24 May 2018

title

The nuclear translocation of endostatin is mediated by its receptor nucleolin in endothelial cells. (English)

1 reference

24 May 2018

0 references

6

1 reference

24 May 2018

author name string

Nan Song

1

1 reference

24 May 2018

Yanping Ding

2

1 reference

24 May 2018

Wei Zhuo

3

1 reference

24 May 2018

Ting He

4

1 reference

24 May 2018

Zhiguang Fu

5

1 reference

24 May 2018

Xiaomin Song

7

1 reference

24 May 2018

Yan Fu

8

1 reference

24 May 2018

Yongzhang Luo

9

1 reference

24 May 2018

publication date

19 June 2012

1 reference

24 May 2018

published in

Angiogenesis

1 reference

24 May 2018

volume

15

1 reference

24 May 2018

issue

4

1 reference

24 May 2018

page(s)

697-711

1 reference

24 May 2018

https://scigraph.springernature.com/pub.10.1007/s10456-012-9284-y

exact match

0 references

cites work

Tumor angiogenesis: therapeutic implications

1 reference

https://api.crossref.org/works/10.1007%2FS10456-012-9284-Y

Endostatin: the logic of antiangiogenic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-012-9284-Y

Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-012-9284-Y

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-012-9284-Y

Two RGD-independent alpha vbeta 3 integrin binding sites on tumstatin regulate distinct anti-tumor properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-012-9284-Y

Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-012-9284-Y

Characterization of the anti-angiogenic properties of arresten, an alpha1beta1 integrin-dependent collagen-derived tumor suppressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-012-9284-Y

A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-012-9284-Y

Angiostatin and endostatin: endothelial cell-specific endogenous inhibitors of angiogenesis and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-012-9284-Y

Molecular interplay between endostatin, integrins, and heparan sulfate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-012-9284-Y

Nucleolin is a receptor that mediates antiangiogenic and antitumor activity of endostatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-012-9284-Y

Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by alpha v beta 3 and alpha 5 beta 1 integrins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-012-9284-Y

Cell surface glypicans are low-affinity endostatin receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-012-9284-Y

The angiogenic function of nucleolin is mediated by vascular endothelial growth factor and nonmuscle myosin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-012-9284-Y

Laminin modulates morphogenic properties of the collagen XVIII endostatin domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-012-9284-Y

Endostatin binds tropomyosin. A potential modulator of the antitumor activity of endostatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-012-9284-Y

Endostatin binds to the catalytic domain of matrix metalloproteinase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-012-9284-Y

Endostatin signaling and regulation of endothelial cell-matrix interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-012-9284-Y

Cholesterol sequestration by nystatin enhances the uptake and activity of endostatin in endothelium via regulating distinct endocytic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-012-9284-Y

Overexpression of platelet-derived growth factor-BB increases tumor pericyte content via stromal-derived factor-1alpha/CXCR4 axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-012-9284-Y

Nuclear translocation of urokinase-type plasminogen activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-012-9284-Y

The actin cytoskeleton is required for receptor-mediated endocytosis in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-012-9284-Y

Molecular mechanism and physiological functions of clathrin-mediated endocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-012-9284-Y

Surface nucleolin participates in both the binding and endocytosis of lactoferrin in target cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-012-9284-Y

Nucleolin, a shuttle protein promoting infection of human monocytes by Francisella tularensis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-012-9284-Y

Direct binding of occupied urokinase receptor (uPAR) to LDL receptor-related protein is required for endocytosis of uPAR and regulation of cell surface urokinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-012-9284-Y

Regulation of alpha5beta1 integrin conformation and function by urokinase receptor binding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-012-9284-Y

Integrin trafficking and tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-012-9284-Y

Importin α: a multipurpose nuclear-transport receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-012-9284-Y

Karyopherins: from nuclear-transport mediators to nuclear-function regulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-012-9284-Y

Unraveling the mysteries of endostatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-012-9284-Y

The N-terminal integrity is critical for the stability and biological functions of endostatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-012-9284-Y

Endostatin causes G1 arrest of endothelial cells through inhibition of cyclin D1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-012-9284-Y

Endostatin blocks vascular endothelial growth factor-mediated signaling via direct interaction with KDR/Flk-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-012-9284-Y

E-selectin is required for the antiangiogenic activity of endostatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-012-9284-Y

Contributions of Zn(II)-binding to the structural stability of endostatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-012-9284-Y

Zinc-dependent dimers observed in crystals of human endostatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-012-9284-Y

A 27-amino-acid synthetic peptide corresponding to the NH2-terminal zinc-binding domain of endostatin is responsible for its antitumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-012-9284-Y

That zincing feeling: the effects of EDTA on the behaviour of zinc-binding transcriptional regulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-012-9284-Y

Cell surface nucleolin antagonist causes endothelial cell apoptosis and normalization of tumor vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-012-9284-Y

Targeting surface nucleolin with multivalent HB-19 and related Nucant pseudopeptides results in distinct inhibitory mechanisms depending on the malignant tumor cell type

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-012-9284-Y

Urokinase-induced mitogenesis is mediated by casein kinase 2 and nucleolin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-012-9284-Y

Functional interaction of hepatitis C Virus NS5B with Nucleolin GAR domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-012-9284-Y

A 110-kD nuclear shuttling protein, nucleolin, binds to the neurite-promoting IKVAV site of laminin-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-012-9284-Y

Nucleolin functions in the first step of ribosomal RNA processing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-012-9284-Y

Nuclear targeting by the growth factor midkine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-012-9284-Y

Interaction of endostatin with integrins implicated in angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-012-9284-Y

Endostatin Associates with Lipid Rafts and Induces Reorganization of the Actin Cytoskeleton via Down-regulation of RhoA Activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-012-9284-Y

10.1007/S10456-012-9284-Y

21 January 2018

Identifiers

DOI

1 reference

24 May 2018

PubMed ID

22711211

1 reference

24 May 2018